UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. Rituximab Therapy and Cellular Immune Response (150)
    George Weiner
  2. A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid (Zometa®) in the Treatment of Bone Disease in Subjects with Newly Diagnosed Multiple Myeloma
    Guido Tricot
  3. Collection of Peripheral Blood Stem Cells Following Stimulation with Filgrastim: A study by the National Marrow Donor Program
    Margarida Magalhaes-Silverman
  4. A research Database for Allogeneic Unrelated Hematopoietic Stem Cell Transplantation
    Colleen Chapleau
  5. Molecular Markers of Chronic Lymphocytic Leukemia
    Daniel Vaena
  6. A Children's Oncology Group Protocol for Collecting and Banking Osteosarcoma Specimens
    Ayman El-Sheikh
  7. High Dose Granulocyte Transfusions for the Treatment of Infection in Neutropenia (The RING Study: Resolving Infection in Neutropenia with Granulocytes) (25)
    Ronald G. Strauss
  8. Consent to Participate in the Neuroendocrine Tumor Registry
    Thomas O'Dorisio
  9. Renal Tumors Classification, Biology and Banking Study (AREN03B2); 0/30
    Ayman El-Sheikh
  10. A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel Alone or in Combination with Bevacizumab (NSC #704865, IND #7921) Followed by Bevacizumab and Secondary Cytoreductive Sur…
    David Bender
  11. Randomized, phase III, double-blind placebo-controlled trial of Sunitinib (NSC #736511, IND #74019) as maintenance therapy in non-progressing patients following an initial four cycles of platinum-base…
    Daniel Vaena
  12. Genetic Epidemiology of B-cell Lymphoproliferative Disorders; SPORE
    Brian Link
  13. A Randomized Trial of Pelvic Irradiation with or without Concurrent Weekly Cisplatin in Patients with Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus
    David Bender
  14. Phase I/II Study Epigenetic Modification of Chemosensitivity and Apoptosis in Metastatic Melanoma: Treatment of a Resistant Disease Using Decitabine, Temozolomide and Panobinostat
    Mohammed Milhem
  15. A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2 -Positive Ductal Carcinoma in Situ Resected by Lumpectomy
    Alexandra Thomas
  16. A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized P…
    Daniel Vaena
  17. A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12 Monthly Cycles of Single Agent Paclitaxel or CT-2103 (IND #70177), versus no Treatment until Documented Relapse in Women with Adva…
    David Bender
  18. Assessment of novel molecular markers in acute myeloid leukemia
    Daniel Vaena
  19. A Randomized, Double-Blinded, Placebo-Controlled, Multi-Institutional, Phase II.5 Study of AZD0530, a Selective Src Kinase Inhibitor, In Patients with Recurrent Osteosarcoma Localized to the Lung (10)…
    Mohammed Milhem
  20. A Phase II Pilot Trial of Bortezomib (PS-341, Velcade┬«, IND# 58,443) in Combination with Intensive Re-Induction Therapy for Children with Relapsed Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic…
    Ayman El-Sheikh

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.